Hugo F. Miranda

2.5k total citations
117 papers, 2.1k citations indexed

About

Hugo F. Miranda is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Hugo F. Miranda has authored 117 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Physiology, 57 papers in Cellular and Molecular Neuroscience and 36 papers in Molecular Biology. Recurrent topics in Hugo F. Miranda's work include Pain Mechanisms and Treatments (72 papers), Neuropeptides and Animal Physiology (41 papers) and Inflammatory mediators and NSAID effects (22 papers). Hugo F. Miranda is often cited by papers focused on Pain Mechanisms and Treatments (72 papers), Neuropeptides and Animal Physiology (41 papers) and Inflammatory mediators and NSAID effects (22 papers). Hugo F. Miranda collaborates with scholars based in Chile, Puerto Rico and Spain. Hugo F. Miranda's co-authors include G. Pinardi, Fernando Sierralta, Juan Carlos Prieto, Margarita M. Puig, Viviana Noriega, C. Paeile, Teresa Pélissier, Juan Carlos Prieto, Diego Bustamante and J. Pablo Huidobro‐Toro and has published in prestigious journals such as Brain Research, Pain and British Journal of Pharmacology.

In The Last Decade

Hugo F. Miranda

113 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugo F. Miranda Chile 28 1.1k 636 578 407 314 117 2.1k
Francisco Javier López‐Muñoz Mexico 29 947 0.9× 504 0.8× 486 0.8× 509 1.3× 155 0.5× 100 2.0k
Werner Englberger Germany 22 806 0.7× 598 0.9× 592 1.0× 261 0.6× 254 0.8× 40 1.7k
Maurizio Sandrini Italy 23 643 0.6× 484 0.8× 406 0.7× 493 1.2× 181 0.6× 63 1.9k
Ahmet Doğrul Türkiye 27 1.4k 1.3× 831 1.3× 557 1.0× 544 1.3× 285 0.9× 79 2.1k
L. Manara Italy 27 723 0.7× 1.2k 1.9× 940 1.6× 342 0.8× 250 0.8× 90 2.3k
Thomas Christoph Germany 29 1.5k 1.4× 841 1.3× 728 1.3× 454 1.1× 379 1.2× 87 2.8k
Niemegeers Cj Belgium 20 417 0.4× 879 1.4× 586 1.0× 210 0.5× 143 0.5× 51 1.8k
Ian M Coupar Australia 24 398 0.4× 779 1.2× 747 1.3× 177 0.4× 318 1.0× 104 2.2k
J Lavarenne France 17 1.0k 0.9× 504 0.8× 293 0.5× 300 0.7× 131 0.4× 79 1.6k
James M. Fujimoto United States 26 1.3k 1.2× 1.3k 2.0× 855 1.5× 257 0.6× 247 0.8× 139 2.4k

Countries citing papers authored by Hugo F. Miranda

Since Specialization
Citations

This map shows the geographic impact of Hugo F. Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo F. Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo F. Miranda more than expected).

Fields of papers citing papers by Hugo F. Miranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo F. Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo F. Miranda. The network helps show where Hugo F. Miranda may publish in the future.

Co-authorship network of co-authors of Hugo F. Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo F. Miranda. A scholar is included among the top collaborators of Hugo F. Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo F. Miranda. Hugo F. Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miranda, Hugo F., et al.. (2018). Synergism between gabapentin–tramadol in experimental diabetic neuropathic pain. Fundamental and Clinical Pharmacology. 32(6). 581–588. 8 indexed citations
2.
Miranda, Hugo F., Fernando Sierralta, P. Poblete, et al.. (2017). Antinociception induced by rosuvastatin in murine neuropathic pain. Pharmacological Reports. 70(3). 503–508. 11 indexed citations
3.
Miranda, Hugo F., et al.. (2015). Antinociceptive Synergism of Gabapentin and Nortriptyline in Mice with Partial Sciatic Nerve Ligation. Pharmacology. 95(1-2). 59–64. 12 indexed citations
4.
Miranda, Hugo F., et al.. (2014). Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain. Journal of Biomedical Science. 21(1). 62–62. 20 indexed citations
5.
Miranda, Hugo F., Viviana Noriega, Ramiro Zepeda, Fernando Sierralta, & Juan Carlos Prieto. (2011). Synergism Between Fentanyl and Tramadol in Tonic Inflammatory Pain: the Orofacial Formalin Test. Inflammation. 35(3). 1132–1137. 8 indexed citations
6.
Romero, Asunción, Hugo F. Miranda, & Margarita M. Puig. (2010). Antinociceptive effects of morphine, fentanyl, tramadol and their combination, in morphine-tolerant mice. Pharmacology Biochemistry and Behavior. 97(2). 363–369. 17 indexed citations
7.
Miranda, Hugo F., José A. Prieto, Mireia Puig, & G. Pinardi. (2007). Isobolographic analysis of multimodal analgesia in an animal model of visceral acute pain. Pharmacology Biochemistry and Behavior. 88(4). 481–486. 26 indexed citations
8.
Pinardi, G., Juan Carlos Prieto, & Hugo F. Miranda. (2005). Analgesic synergism between intrathecal morphine and cyclooxygenase-2 inhibitors in mice. Pharmacology Biochemistry and Behavior. 82(1). 120–124. 27 indexed citations
9.
Miranda, Hugo F., Igor Lemus, & G. Pinardi. (2003). Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs. Brain Research Bulletin. 61(4). 417–425. 29 indexed citations
10.
Miranda, Hugo F., Fernando Sierralta, & G. Pinardi. (2002). Carbachol interactions with nonsteroidal anti-inflammatory drugs. Canadian Journal of Physiology and Pharmacology. 80(12). 1173–1179. 2 indexed citations
11.
Bustamante, Diego, et al.. (2000). Progesterone and Testosterone Modulate the Convulsant Actions of Pentylenetetrazol and Strychnine in Mice. Pharmacology & Toxicology. 87(3). 116–119. 29 indexed citations
12.
Prieto, Juan Carlos, et al.. (2000). Isobolographic Analysis of the Interaction Between Fenoldopam and Levodopa on Arterial Blood Pressure of the Rat. Journal of Cardiovascular Pharmacology. 36(3). 413–415. 1 indexed citations
13.
Sierralta, Fernando, et al.. (1996). α‐Adrenoceptor and opioid receptor modulation of clonidine‐induced antinociception. British Journal of Pharmacology. 119(3). 551–554. 42 indexed citations
14.
Miranda, Hugo F., et al.. (1991). Pharmacological actions of substance P in the rat vas deferens. Neuropeptides. 18(4). 209–213. 3 indexed citations
15.
Saavedra, Herbert, Hugo F. Miranda, Diego Bustamante, Teresa Pélissier, & C. Paeile. (1990). Evidence that the action of clonixin is non-dependent of ACh release. General Pharmacology The Vascular System. 21(4). 447–450. 1 indexed citations
16.
Bustamante, Diego, et al.. (1988). Effects of clonixin, a non-steroidal analgesic, on the neurotransmission of the vas deferens of the rat. General Pharmacology The Vascular System. 19(6). 755–758. 6 indexed citations
17.
Miranda, Hugo F., et al.. (1985). Presynaptic Regulation by ACh of the NE Mediated Responses in the Rat Vas Deferens. Journal of Receptor Research. 5(4). 231–243. 18 indexed citations
18.
Paeile, C., et al.. (1984). Natural resistance to effects of morphine in Octodon degus a south American rodent. 5(1). 11–22. 1 indexed citations
19.
Miranda, Hugo F., et al.. (1984). Testosterone and tolerance in rat vas deferens. General Pharmacology The Vascular System. 15(6). 529–533. 1 indexed citations
20.
Huidobro, F & Hugo F. Miranda. (1968). The presence in mice chronically treated with morphine of a substance (S) that modifies morphine responses. Biochemical Pharmacology. 17(6). 1099–1105. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Javier López‐Muñoz Breakdown of academic impact, for papers by Werner Englberger Breakdown of academic impact, for papers by Maurizio Sandrini Breakdown of academic impact, for papers by Ahmet Doğrul Breakdown of academic impact, for papers by L. Manara Breakdown of academic impact, for papers by Thomas Christoph Breakdown of academic impact, for papers by Niemegeers Cj Breakdown of academic impact, for papers by Ian M Coupar Breakdown of academic impact, for papers by J Lavarenne Breakdown of academic impact, for papers by James M. Fujimoto
Rankless by CCL
2026